Q5T7S2 (Q5T7S2_HUMAN) Homo sapiens (Human)

TGF-beta receptor type-1 UniProtKBInterProInteractive Modelling

503 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P36897

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
1b6c
 Heteromer
P36897; P62942; 		175-500
1×SO4;
Assess
Ternary structure of GDF11 bound to ActRIIB-ECD and Alk5-ECD
6mac
 Heteromer
O95390; P36897; P38445; 		33-112
4×NAG;
Assess
Structural basis for cooperative assembly of the TGF-beta signaling complex
2pjy
 Heteromer
P10600; P36897; P37173; 		33-111
Assess
Ternary complex of TGF-b1 reveals isoform-specific ligand recognition and receptor recruitment in t…
3kfd
 Heteromer
P01137; P36897; P37173; 		33-109
Assess
CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
1ias
homo-5-mer171-501
15×SO4;
Assess
Crystal structure of TGFbRI complexed with a pyrazolone inhibitor
3kcf
monomer171-500
1×JZO; 3×PO4;
Assess
Crystal structure of TGFbRI complexed with a 2-aminoimidazole inhibitor
3faa
monomer171-500
1×55F; 3×PO4;
Assess
Crystal structure of TGFbRI complexed with an indolinone inhibitor
2x7o
monomer171-500
1×ZOP;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) IN COMPLE…
5e8x
monomer200-503
1×STU; 1×GOL;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3-fluoropyridin-4-yl)-2-[6-(trifl…
6b8y
monomer200-502
1×D0A;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[4-(3-CHLORO-4-FLUOROPHENYL)-1-(2-…
5qu0
monomer200-502
1×QMV; 1×GOL;
Assess
Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor
1vjy
monomer201-503
1×460;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F)
5e8u
monomer200-502
3×GOL;
Assess
The Crystal Structure of Tgf-Beta Type I Receptor (Alk5) from Biortus
8yhl
monomer200-501
1×A1D6I; 2×EDO; 2×ACT;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x2f
monomer200-501
1×3WJ; 1×SO4;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x2g
monomer200-501
1×3WK; 1×SO4; 1×TRS;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x0m
monomer200-501
1×3WA; 1×SO4;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x2j
monomer200-501
1×3WN; 1×SO4;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x2k
monomer200-501
1×3WO; 1×SO4;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(5-METHOXYPYRIDIN-2-YL)-1H-P…
5qim
monomer200-501
1×J2Y; 1×GOL;
Assess
Selection of fragments for kinase inhibitor design: decoration is key
4x2n
monomer200-501
1×SO4;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINE
5e8w
monomer200-501
1×STU; 2×GOL;
Assess
ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridi…
2wot
monomer200-500
1×ZZG; 1×EDO;
Assess
Crystal Structure of TGF-beta receptor I kinase with inhibitor
1py5
monomer200-500
1×SO4; 1×PY1;
Assess
Crystal Structure of TGF-beta receptor I kinase with ATP site inhibitor
1rw8
monomer200-500
1×580;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3-AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]…
5e8z
monomer200-499
1×5L4;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-fluoropyridin-3-yl)-4-oxo…
5qik
monomer200-499
1×J2M; 2×GOL;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D)
5e8t
monomer200-499
3×GOL;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYL…
5qtz
monomer200-499
1×QMY; 3×GOL;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-P…
5qil
monomer200-499
1×J2V;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLE…
5e90
monomer200-499
1×5L4;
Assess
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT)
5e8s
monomer200-498
Assess
ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor.
5fri
monomer200-498
2×EDO; 1×ZUQ;
Assess
ALK-5 kinase inhibitor complex
5usq
monomer200-498
1×8LY;
Assess
The Crystal Structure of the Type I TGF beta receptor from Biortus.
8yhf
monomer201-498
1×A1D6I;
Assess
Structure of Alk5 + GW855857
3hmm
monomer201-498
1×855;
Assess
ALK-5 kinase complex with GW857175
3gxl
monomer201-498
1×QIG;
Assess
TGF-beta Receptor type 1 in complex with SB431542
3tzm
monomer200-496
1×085;
Assess
ALK5 IN COMPLEX WITH 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamide
2wou
monomer200-496
1×EDO; 1×ZZF;
Assess
Solution structure of the extracellular domain of the TGF-beta type I receptor
2l5s
monomer31-115
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1ias.1.Ahomo-5-mer0.80171-501
100.00
Assess